申请人:Dow Robert Lee
公开号:US20120270893A1
公开(公告)日:2012-10-25
The invention provides a compound of Formula (I)
or a pharmaceutically acceptable salt thereof; wherein
G is
R
1
, R
2
and R
3
are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
该发明提供了公式(I)的化合物或其药用可接受的盐;其中G为R1,R2和R3如本文所述;其药用组合物;以及其在治疗由于抑制动物中乙酰辅酶A羧化酶而调节的疾病、症状或疾病中的用途。